Prevalence of antineutrophil cytoplasmic antibodies in patients with various pulmonary diseases or multiorgan dysfunction.

OBJECTIVE To determine the prevalence of antineutrophil cytoplasmic antibodies (ANCA) in patients with diseases that may mimic systemic vasculitides, such as severe multiorgan dysfunction (MOD) and parenchymal pulmonary disorders. METHODS We conducted a prospective study of patients with MOD admitted to the medical intensive care unit and patients with various lung diseases seen at the outpatient pulmonary clinic of a tertiary care hospital. Patients with a documented diagnosis of Wegener's granulomatosis (WG) served as positive controls. ANCA were determined in serum samples from each patient by a combination of indirect immunofluorescence (IIF) and enzyme-linked immunosorbent assays (ELISAs) for antibodies to proteinase-3 and myeloperoxidase (anti-MPO). RESULTS Ninety-nine patients with MOD, 29 outpatients with various lung disorders, and 18 patients with WG were included in the study. ANCA were detected by IIF alone in 16% (15/96) of patients with nonvasculitic MOD and 17% (5/29) of outpatients with various pulmonary disorders. The majority of the positive IIF specimens from each group displayed an atypical IIF pattern (73% and 80%, respectively). Only 1 specimen from patients with nonvasculitic disorders was positive for anti-MPO. ANCA by both IIF and ELISA were detected in 78% (12/14) of control patients with WG. CONCLUSION Detection of ANCA by the combination of IIF and antigen-specific assays for proteinase 3 and myeloperoxidase in diseases that mimic systemic vasculitides is highly specific for WG, microscopic polyangiitis, and Churg-Strauss syndrome.

[1]  D A Bloch,et al.  The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. , 2010, Arthritis and rheumatism.

[2]  R. Gans,et al.  Antiproteinase 3- and antimyeloperoxidase-associated vasculitis. , 2000, Kidney international.

[3]  R. Falk,et al.  ANCA glomerulonephritis and vasculitis: a Chapel Hill perspective. , 2000, Seminars in nephrology.

[4]  P. Merkel,et al.  Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: prevalence among patients with high titers of antimyeloperoxidase antibodies. , 2000, Arthritis and rheumatism.

[5]  D. Vassilopoulos,et al.  Clinical Utility of Testing for Antineutrophil Cytoplasmic Antibodies , 1999, Clinical Diagnostic Laboratory Immunology.

[6]  G. Hoffman,et al.  Antineutrophil cytoplasmic antibodies. , 1998, Bulletin on the rheumatic diseases.

[7]  P. Lamprecht,et al.  ANCA, infectious endocarditis, glomerulonephritis and cryoglobulinemic vasculitis. , 1998, Clinical nephrology.

[8]  P Lesavre,et al.  Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization. , 1998, Kidney international.

[9]  R. Bayoumi,et al.  Anti‐neutrophil cytoplasmic antibody (ANCA) in malaria is directed against cathepsin G , 1997, Clinical and experimental immunology.

[10]  A. Wiik,et al.  Rapid screening assay for anti-GBM antibody and ANCAs; an important tool for the differential diagnosis of pulmonary renal syndromes. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[11]  P. Merkel,et al.  Prevalence of Antineutrophil Cytoplasmic Antibodies in a Large Inception Cohort of Patients with Connective Tissue Disease , 1997, Annals of Internal Medicine.

[12]  J. T. ter Maaten,et al.  Respiratory failure in ANCA-associated vasculitis. , 1996, Chest.

[13]  E. Böttinger,et al.  The syndrome of lung hemorrhage and nephritis is usually an ANCA-associated condition. , 1996, Archives of internal medicine.

[14]  Eugene Oddone,et al.  The Role of Antineutrophil Cytoplasmic Antibody (c-ANCA) Testing in the Diagnosis of Wegener Granulomatosis: A Literature Review and Meta-analysis , 1995, Annals of Internal Medicine.

[15]  C. Sprung,et al.  Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. , 1995, Critical care medicine.

[16]  R. Saxena,et al.  Circulating autoantibodies as serological markers in the differential diagnosis of pulmonary renal syndrome , 1995, Journal of internal medicine.

[17]  A. Tatum,et al.  False-positive antineutrophil cytoplasmic antibody in aspergillosis with oxalosis. , 1995, Archives of Pathology & Laboratory Medicine.

[18]  R J Falk,et al.  Nomenclature of systemic vasculitides. Proposal of an international consensus conference. , 1994, Arthritis and rheumatism.

[19]  S. Skates,et al.  Antigen-specific radioimmunoassays for anti-neutrophil cytoplasmic antibodies in the diagnosis of rapidly progressive glomerulonephritis. , 1991, Journal of the American Society of Nephrology : JASN.

[20]  P. Merkel,et al.  Subacute bacterial endocarditis with positive cytoplasmic antineutrophil cytoplasmic antibodies and anti-proteinase 3 antibodies. , 2000, Arthritis and rheumatism.

[21]  S. Mezzano,et al.  Incidence and studies on antigenic specificities of antineutrophil-cytoplasmic autoantibodies (ANCA) in poststreptococcal glomerulonephritis. , 1997, Clinical nephrology.